We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-21.35%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2.43B
AUM Growth
-$314M
Cap. Flow
-$88.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
48.1%
Holding
447
New
130
Increased
120
Reduced
90
Closed
66

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$38.8M
2
BIIB icon
Biogen
BIIB
+$26M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$23.3M
4
VTRS icon
Viatris
VTRS
+$21M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$16.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$28.9M
2
MRK icon
Merck
MRK
+$17.9M
3
XOM icon
ExxonMobil
XOM
+$14.8M
4
ZGNX
Zogenix, Inc.
ZGNX
+$13.4M
5
LPCN icon
Lipocine
LPCN
+$7.13M

Sector Composition

Rank Sector Weight
1 Healthcare 13.39%
2 Energy 1.08%
3 Technology 0.46%
4 Materials 0.45%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
401
PUT
ExxonMobil
XOM
$634B
– –
-2,933
Closed -$24.4M
VIVS
402
VivoSim Labs
VIVS
$1.33M
– –
-1,207
Closed -$1.09M
VIRX
403
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-1,167
Closed -$738K
VIRX
404
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-24
Closed -$1.53M
NBSE
405
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-225
Closed -$226K
ATHX
406
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-90
Closed -$272K
MNK
407
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-127
Closed -$1.5M
MNK
408
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-40,539
Closed -$4.77M
MNK
409
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-980
Closed -$11.5M
PGNX
410
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-247,706
Closed -$1.9M
PGNX
411
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-3,369
Closed -$2.51M
BLPH
412
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
– –
-2,382
Closed -$283K
ACHN
413
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-18,835
Closed -$153K
MDCO
414
PUT
DELISTED
Medicines Co
MDCO
– –
-803
Closed -$2.3M
APC
415
CALL
DELISTED
Anadarko Petroleum
APC
– –
-580
Closed -$4.53M
HIFR
416
CALL
DELISTED
InfraREIT, Inc.
HIFR
– –
-690
Closed -$1.96M
NXTM
417
DELISTED
NxStage Medical Inc.
NXTM
– –
-50,542
Closed -$722K
TSRO
418
CALL
DELISTED
TESARO, Inc.
TSRO
– –
-89
Closed -$523K
CVM.WS
419
DELISTED
Cel-Sci Corp Series S
CVM.WS
– –
-1,845,841
Closed -$369K
JUNO
420
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-11,333
Closed -$604K
JUNO
421
PUT
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-130
Closed -$693K
PVCT.WS
422
DELISTED
PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
– –
-749,337
Closed -$164K
HTWR
423
CALL
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-50
Closed -$363K
XNPT
424
CALL
DELISTED
XENOPORT, INC.
XNPT
– –
-434
Closed -$266K
OCAT
425
DELISTED
OCATA THERAPEUTICS, INC. COMMON STOCK
OCAT
– –
-352,544
Closed -$1.86M
14 15 16
17
18

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sabby Management held 447 positions worth $2.43B, down 11% from $2.74B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sabby Management withdrew a net $88.1M in Q3 2015, closing 66 positions and reducing 90 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $28.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.3% a quarter earlier, followed by Energy and Technology.

Against the trend, Sabby Management opened a new position in iShares Russell 2000 ETF worth $35.7M.

  • Sabby Management's largest Q3 2015 buy was iShares Russell 2000 ETF: 327,168 shares worth $35.7M.
  • Sabby Management added most to Mobileye N.V. in Q3 2015, an estimated $8.9M increase.
  • Sabby Management's biggest Q3 2015 reduction was Lipocine, cutting an estimated $7.13M.
  • Sabby Management fully exited iShares 20+ Year Treasury Bond ETF in Q3 2015, selling an estimated $28.9M.
  • Sabby Management's ten largest holdings make up 48% of its $2.43B portfolio in Q3 2015.
  • Sabby Management opened 130 new positions and closed 66 in Q3 2015.
  • Sabby Management's portfolio value fell 11% quarter-over-quarter to $2.43B.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.